Heart and Vascular Center, Semmelweis University, 68 Városmajor utca, Budapest, Hungary.
Europace. 2018 Sep 1;20(9):1506-1512. doi: 10.1093/europace/eux342.
There are previous studies on quality of life (QoL) in cardiac resynchronization therapy (CRT) patients; however, there are no data with the short EuroQol-five dimensions (EQ-5D) questionnaire predicting outcomes. We aimed to assess the predictive role of baseline QoL and QoL change at 6 months after CRT with EQ-5D on 5-year mortality and response.
In our prospective follow-up study, 130 heart failure (HF) patients undergoing CRT were enrolled. Clinical evaluation, echocardiography, and EQ-5D were performed at baseline and at 6 months of follow-up, continued to 5 years. Primary endpoint was all-cause mortality at 5 years. Secondary endpoints were (i) clinical response with at least one class improvement in New York Heart Association without HF hospitalization and (ii) reverse remodelling with 15% reduction in left ventricular end-systolic volume at 6 months. Fifty-four (41.5%) patients died during 5 years, 85 (65.3%) clinical responders were identified, and 63 patients (48.5%) had reverse remodelling. Baseline issues with mobility were associated with lower response [odds ratio (OR) 0.36, 95% confidence interval (CI) 0.16-0.84; P = 0.018]. Lack of reverse remodelling correlated with self-care issues at baseline (OR 0.10, 95% CI 0.01-0.94; P = 0.04). Furthermore, self-care difficulties [hazard ratio (HR) 2.39, 95% CI 1.17-4.86; P = 0.01) or more anxiety (HR 1.51, 95% CI 1.00-2.26; P = 0.04) predicted worse long-term survival. At 6 months, mobility (HR 3.95, 95% CI 1.89-8.20; P < 0.001), self-care (HR 7.69, 95% CI 2.23-25.9; P = 0.001), or ≥ 10% visual analogue scale (VAS) (HR 2.24, 95% CI 1.27-3.94; P = 0.005) improvement anticipated better survival at 5 years.
EuroQol-five dimension is a simple method assessing QoL in CRT population. Mobility issues at baseline are associated with lower clinical response, whereas self-care issues predict lack of reverse remodelling. Problems with mobility or anxiety before CRT and persistent issues with mobility, self-care, and VAS scale at 6 months predict adverse outcome.
已有研究探讨了心脏再同步治疗(CRT)患者的生活质量(QoL);然而,尚无使用短版欧洲五维健康量表(EQ-5D)预测结局的相关数据。我们旨在评估基线 QoL 以及 CRT 后 6 个月 EQ-5D 评分变化对 5 年死亡率和反应的预测作用。
在我们前瞻性随访研究中,纳入了 130 名接受 CRT 的心力衰竭(HF)患者。在基线和随访 6 个月时进行临床评估、超声心动图和 EQ-5D 检查,持续至 5 年。主要终点为 5 年全因死亡率。次要终点为(i)纽约心脏协会(NYHA)心功能分级至少改善 1 级且无 HF 住院的临床反应,以及(ii)左心室收缩末期容积在 6 个月时减少 15%的逆重构。5 年内有 54 例(41.5%)患者死亡,85 例(65.3%)为临床反应者,63 例(48.5%)发生逆重构。基线时活动能力存在问题与较低的反应相关[比值比(OR)0.36,95%置信区间(CI)0.16-0.84;P=0.018]。缺乏逆重构与基线时自我护理问题相关(OR 0.10,95%CI 0.01-0.94;P=0.04)。此外,自我护理困难[风险比(HR)2.39,95%CI 1.17-4.86;P=0.01]或更严重的焦虑(HR 1.51,95%CI 1.00-2.26;P=0.04)预示着长期预后更差。在 6 个月时,活动能力(HR 3.95,95%CI 1.89-8.20;P<0.001)、自我护理(HR 7.69,95%CI 2.23-25.9;P=0.001)或≥10%视觉模拟量表(VAS)(HR 2.24,95%CI 1.27-3.94;P=0.005)改善预示着 5 年时的生存更好。
EQ-5D 是评估 CRT 人群 QoL 的简单方法。基线时活动能力存在问题与较低的临床反应相关,而自我护理问题则预示着缺乏逆重构。CRT 前活动能力或焦虑问题以及 6 个月时活动能力、自我护理和 VAS 评分持续存在问题与不良结局相关。